World-renowned cancer centers and Illumina, Inc. (NASDAQ:ILMN) today
announced the formation of the Actionable Genome Consortium (AGC), an
effort to recommend openly published standards for the widespread use of
next-generation sequencing to guide decision-making in clinical
today announced $18 million in grants to Houston health care facilities
to support cancer prevention and cardiovascular research, expand
pediatric care for children with autism and enhance pediatric liver
disease research and clinical services.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.